Delivery Order SPE2DB22D3016-SPE2DB24FAFC2
- Not listed
- This federal contract award, valued at $5,843.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen...
- This federal contract award, valued at $2,320.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product. The award is a delivery order with a firm fixed price and has an ultimate completion date of May 3, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $4,535.82, is for the delivery of Lidocaine 5% Patches and is a firm-fixed price delivery order with a completion date of January 23, 2023. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $1,864.80, is for the delivery of Lidocaine 5% Patch 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of May 6, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying...
- This federal contract award, valued at $6,197.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lidocaine 5% Patch 30s. The contract has an ultimate completion date of December 19, 2023 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that serves as a critical supplier of pharmaceutical products and medical supplies to various...
- This federal contract award, valued at $2,305.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of 4557274756 - Lidocaine 5% Patch 30S, with a completion date of May 19, 2022. The contract is a firm fixed-price delivery order without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $15,053.06 delivery order is for the supply of 4561664612 - Lidocaine 5% Patch 30s, a pharmaceutical product. The contract has a firm fixed price pricing structure and an ultimate completion date of August 2, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,729.60 firm fixed-price delivery order is for Lidocaine 5% Patch 30s, a pharmaceutical product. The contract has an ultimate completion date of May 3, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $7,091.08, is for the procurement of Lidocaine 5% Patch 30s, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 22, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
- This federal contract award, with a ceiling value of $5,275.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, and was awarded as a Delivery Order with a Firm Fixed Price pricing type. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FAFC2Delivery Order
This federal contract award, valued at $5,305.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for Lidocaine 5% Patch 30s, a pharmaceutical product. The contract has an ultimate completion date of December 7, 2023 and a firm fixed price pricing type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide. This contract award is not designated with a set-aside requirement, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 12/6/23 |